Alzheimer'S Disease Clinical Trials in Los Angeles, CA

Alzheimer'S Disease Clinical Trials in Los Angeles, CA

View the best 10 alzheimer's disease medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Alzheimer'S Disease clinical trial.

Trials in Los Angeles, California

Here are the top 10 medical studies for alzheimer's disease in Los Angeles, California

Image of Banner Sun Health Research Institute in Sun City, United States.

Escitalopram

Selective Serotonin Reuptake Inhibitor

Recruiting2 awardsPhase 3
This trial will test whether the antidepressant escitalopram is effective and safe for treating agitation in Alzheimer's dementia.
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.
Image of K2 Medical Research, LLC in Maitland, United States.

BIIB080

Monoclonal Antibodies

Verified
Recruiting0 awardsPhase 2
This trial is testing a study drug called BIIB080 for people with mild cognitive impairment or mild dementia due to AD. The goal is to see if the drug can slow the worsening of AD more than placebo.
Image of Indago Research & Health Center in Hialeah, United States.

Remternetug

Recruiting1 awardPhase 3
This trial aims to see if a new drug can delay memory or thinking problems in Alzheimer's disease compared to a placebo. Participants will be in the study for up to 255 weeks, including treatment and
Image of University of Alabama in Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2 & 3
This trial tests two drugs, lecanemab and E2814, in people with a genetic mutation that causes Alzheimer's disease. Lecanemab helps remove harmful protein clumps from the brain, while E2814 prevents harmful protein tangles from forming. The goal is to see if these drugs can slow down or improve symptoms of Alzheimer's.
Image of UCLA Semel Institute for Neuroscience and Behavior in Los Angeles, United States.

Low-Intensity Focused Ultrasound Pulsation (LIFUP)

Device

Recruiting0 awards
This trial is testing whether a new brain stimulation technique can improve memory in people with early Alzheimer's disease.
Image of University of California San Diego in La Jolla, United States.

Care2Sleep

Behavioural Intervention

Recruiting0 awards5 criteria
This trial tests the Care2Sleep program, which helps people improve their sleep through several educational sessions. It targets pairs of people and caregivers to enhance their sleep, health, and quality of life. The program is available both in-person and online.
Image of California Clinical Trials Medical Group, Inc in Glendale, United States.

OLX-07010

Tau Self-Association Inhibitor

Recruiting0 awardsPhase 1
This trial tests the safety, tolerability, and effects of a tau self-association inhibitor in healthy adults and elderly, with & without food.
Image of Collaborative Neuroscience Research, LLC ( Site 0009) in Long Beach, United States.

MK-2214

Recruiting0 awardsPhase 1
This trial is testing a new drug called MK-2214 to see if it is safe and how it behaves in the body. It targets adults with early memory and thinking problems, like mild cognitive impairment or mild-to-moderate Alzheimer's Disease. Researchers want to know if the drug reaches helpful levels in the brain fluid and stays there long enough to potentially help these conditions.
Image of Clinical Trial Site in Chandler, United States.

KarXT

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial is testing KarXT, a medication for adults aged 55-90 with Alzheimer's Disease and severe psychosis. The goal is to see if KarXT can reduce symptoms like hallucinations and delusions by balancing brain chemicals.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.